ArticleEye and vision (London, England)2022

Comparison of efficacy and safety of intravitreal ranibizumab and conbercept before vitrectomy in Chinese proliferative diabetic retinopathy patients: a prospective randomized controlled trial.

Siying Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.